openPR Logo
Press release

Investigation for Investors in shares of Kezar Life Sciences, Inc. (NASDAQ: KZR) announced

07-24-2019 06:24 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Kezar Life Sciences, Inc. (NASDAQ: KZR) shares over potential securities laws violations.

An investigation for investors in Kezar Life Sciences, Inc. (NASDAQ: KZR) shares over potential securities laws violations.

Kezar Life Sciences, Inc. (NASDAQ: KZR) is under investigation over potential securities laws violations in connection with certain financial statements.

Investors who purchased shares of Kezar Life Sciences, Inc. (NASDAQ: KZR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Kezar Life Sciences, Inc. (NASDAQ: KZR) concerning whether a series of statements by Kezar Life Sciences, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

San Francisco, CA based Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of small molecule therapeutics to treat unmet needs in autoimmunity and cancer in the United States. Kezar Life Sciences, Inc. went public in June 2018 and sold 5 million shares at $15 per share.

Since then, shares of Kezar Life Sciences, Inc. (NASDAQ: KZR) declined to as low as $5.65 per share on July 18, 2019.

On July 23, 2019, NASDAQ: KZR shares closed at $6.00 per share.

Those who purchased shares of Kezar Life Sciences, Inc. (NASDAQ: KZR) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation for Investors in shares of Kezar Life Sciences, Inc. (NASDAQ: KZR) announced here

News-ID: 1810605 • Views: 336

More Releases from Shareholders Foundation

Investigation announced for Long-Term Investors in Ruhnn Holding Limited (NASDAQ …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Ruhnn Holding Limited. Investors who are current long term investors in Ruhnn Holding Limited (NASDAQ: RUHN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in Ruhnn Holding Limited (NASDAQ: RUHN stocks follows a lawsuit
Investigation announced for Investors in shares of Fluor Corporation (NYSE: FLR)
Fluor Corporation is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Fluor Corporation (NYSE: FLR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Fluor Corporation regarding its business, its prospects and its operations were materially false and misleading at
Lawsuit filed for Investors in shares of JELD-WEN Holding, Inc. (NYSE: JELD)
An investor, who purchased shares of JELD-WEN Holding, Inc. (NYSE: JELD), filed a lawsuit over alleged violations of Federal Securities Laws by JELD-WEN Holding, Inc.. Investors who purchased shares of JELD-WEN Holding, Inc. (NYSE: JELD) have certain options and for certain investors are short and strict deadlines running. Deadline: April 20, 2020. NYSE: JELD investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Charlotte, NC based JELD-WEN
Celanese Corporation (NYSE: CE) Investor Investigation over possible Violations …
An investigation was announced over potential securities laws violations by Celanese Corporation in connection with certain financial statements. Investors who purchased shares of Celanese Corporation (NYSE: CE), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Celanese Corporation (NYSE: CE) concerning whether a series of

All 5 Releases


More Releases for Kezar

Rheumatoid Arthritis – Diseases & Therapeutic Pipeline Review, H1 2018 Coverin …
HTF Market Report released a new research document of 1016 pages on industry titled as 'Rheumatoid Arthritis - Pipeline Review, H1 2018' with detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes important players/vendors such as Adello Biologics LLC, Alteogen , Amarna Therapeutics BV, Amgen, Applied Genetic Technologies etc The report will help you gain market insights, future trends and growth prospects for forecast period. Request